Potential Benefits Drive Interest in Continuous Manufacturing

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2014
Volume 2014 eBook
Issue 2

Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.

Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.

Download

Pharmaceutical Technology’s 2014 Bioprocessing and Sterile Manufacturing eBook

.

 

 

 

 

 

 

 

 

Articles in this issue
Continious-Biopharma185.jpg
Potential Benefits Drive Interest in Continuous Manufacturing
stephaniedubois200.jpg
Continuous Bioprocessing Challenges
PTebook0514_Cross-Contamination185.jpg
Determining Cross-Contamination Risks in Multiproduct Biopharmaceutical Facilities
PTebook0514_Continuous-Monitoring_1851431659146699.jpg
Achieving and Maintaining Compliance Using Continuous Monitoring Systems
PTebook0514_Telstar185.jpg
Optimizing the Sterilization of Liquids in Sealed Containers
par-almhelm200.jpg
Using Modular Systems in Biopharmaceutical Manufacturing
PTebook_Genzyme185.jpg
Determining Protein Oxidation Induced During Fill-Finish Operations
PTebook0514_SingleUse_185.jpg
Single-Use Technology in Parenteral Fill/Finish
Recent Videos
Related Content
TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novartis to Expand US-Based R&D and Manufacturing

Susan Haigney
April 11th 2025
Article

The company has plans to invest $23 billion during the next five years to expand manufacturing and R&D in the US, which will include seven new facilities.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Microsoft and SkyCell Collaborate on Pharma Supply Chain Logistics

Susan Haigney
April 9th 2025
Article

SkyCell is working with Microsoft to incorporate SkyCell’s AI-powered supply chain solution into Microsoft Teams and Copilot.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Electronic three dimensional plastic printer during work | Image Credit: © andrew_shots - stock.adobe.com

Entering New Domains for 3D Printing of Drug Products

Anna Kirstine Jørgensen;Alvaro Goyanes;Abdul W. Basit
April 6th 2025
Article

3D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.

The show floor at INTERPHEX 2025. | Image Credit: © Patrick Lavery/PharmTech Group

Recapping INTERPHEX 2025: Pharma Looks Toward the Future

Patrick Lavery
April 4th 2025
Article

The yearly convention in New York City showcased new and emerging technologies and gave participating exhibitors a chance to unveil their strategies for the second half of the 2020s.